HIGHER EXPRESSION OF TOPOISOMERASE-II IN LUNG CANCERS THAN NORMAL LUNG TISSUES - DIFFERENT EXPRESSION PATTERN FROM TOPOISOMERASE-I

被引:20
|
作者
HASEGAWA, T [1 ]
ISOBE, K [1 ]
NAKASHIMA, I [1 ]
SHIMOKATA, K [1 ]
机构
[1] NAGOYA UNIV,SCH MED,DEPT IMMUNOL,NAGOYA,AICHI 466,JAPAN
关键词
D O I
10.1006/bbrc.1993.2058
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To examine the expression of topoisomerase I and topoisomerase II in primary lung cancer specimens at mRNA level, we carried out Northern blot analysis. As for topoisomerase I expression, there was no remarkable difference between lung cancer specimens and non-cancerous lung tissues. On the other hand, we could detect topoisomerase II mRNA in almost all lung cancer specimens, but not in non-cancerous tissues. By Southern blot analysis, we could not detect large deletion nor rearrangement in DNA level. These results suggest that the expression of topoisomerase II is highly increased in lung cancer at mRNA level and drugs against topoisomerase II might be more tumor-specific than those against topoisomerase I. © 1993 Academic Press. All rights reserved.
引用
收藏
页码:409 / 414
页数:6
相关论文
共 50 条
  • [1] Evaluation of topoisomerase I gene expression in matched normal lung tissues and lung cancers.
    Kolesar, J
    Paulson, K
    Miller, J
    McLeod, H
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3736S - 3736S
  • [2] TOPOISOMERASE-I AND TOPOISOMERASE-II ACTIVITY IN HUMAN BREAST, CERVIX, LUNG AND COLON-CANCER
    MCLEOD, HL
    DOUGLAS, F
    OATES, M
    SYMONDS, RP
    PRAKASH, D
    VANDERZEE, AGJ
    KAYE, SB
    BROWN, R
    KEITH, WN
    INTERNATIONAL JOURNAL OF CANCER, 1994, 59 (05) : 607 - 611
  • [3] ALTERED TOPOISOMERASE-I AND TOPOISOMERASE-II ACTIVITIES IN SURAMIN-RESISTANT LUNG FIBROSARCOMA CELLS
    LELIEVRE, S
    BENCHOKROUN, Y
    LARSEN, AK
    MOLECULAR PHARMACOLOGY, 1995, 47 (05) : 898 - 906
  • [4] SIMULTANEOUS PURIFICATION OF DNA TOPOISOMERASE-I AND TOPOISOMERASE-II FROM EUKARYOTIC CELLS
    STRAUSFELD, U
    RICHTER, A
    PREPARATIVE BIOCHEMISTRY, 1989, 19 (01): : 37 - 48
  • [5] ACTIVITIES OF DNA TOPOISOMERASE-I AND TOPOISOMERASE-II IN HUMAN-BLOOD LYMPHOCYTES DERIVED FROM NORMAL AND LEUKEMIC INDIVIDUALS
    SAHAI, BM
    KULLMAN, I
    KAPLAN, JG
    FEDERATION PROCEEDINGS, 1986, 45 (06) : 1591 - 1591
  • [6] EXPRESSION OF TOPOISOMERASE-II-ALPHA AND TOPOISOMERASE-II-BETA IN CHINESE-HAMSTER LUNG-CELLS RESISTANT TO TOPOISOMERASE-II INHIBITORS
    KHELIFA, T
    CASABIANCAPIGNEDE, MR
    RENE, B
    JACQUEMINSABLON, A
    MOLECULAR PHARMACOLOGY, 1994, 46 (02) : 323 - 328
  • [7] MESSENGER-RNA EXPRESSION OF TOPOISOMERASE-II IN HUMAN TUMORS AND NORMAL-TISSUES
    KIM, R
    HIRABAYASHI, N
    NISHIYAMA, M
    YORISHIMA, T
    TOGE, T
    OKADA, K
    JAPANESE JOURNAL OF SURGERY, 1991, 21 (05): : 587 - 589
  • [8] ANALYSIS OF EXPRESSION OF TOPOISOMERASE-I AND TOPOISOMERASE-II-ALPHA DURING SPERMATOGENESIS IN MICE
    HANDEL, MA
    REDDY, RK
    BIOLOGY OF REPRODUCTION, 1995, 52 : 192 - 192
  • [9] EVALUATION OF NOVEL PLATINUM COMPLEXES, INHIBITORS OF TOPOISOMERASE-I AND TOPOISOMERASE-II IN NONSMALL CELL LUNG-CANCER (NSCLC) SUBLINES RESISTANT TO CISPLATIN
    FUKUDA, M
    OHE, Y
    KANZAWA, F
    OKA, M
    HARA, K
    SAIJO, N
    ANTICANCER RESEARCH, 1995, 15 (02) : 393 - 398
  • [10] Clinical Significance of Topoisomerase-II Expression in Patients with Relapsed HGNEC of the Lung Treated with Amrubicin
    Miura, Y.
    Kaira, K.
    Sakurai, R.
    Tomizawa, Y.
    Tsukagoshi, Y.
    Masuda, T.
    Kasahara, N.
    Sunaga, N.
    Saito, R.
    Hisada, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2189 - S2189